StreetInsider.com News Articles

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

Tue, 01 Sep 2026 08:30:00 -0400

Company to Highlight Growth Strategy and Readiness for 2026 Commercial Launch of FDA-Cleared DeepView® System for Burn Indication

DALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Vincent Capone, Chief Executive Officer, and David McGuire, Chief Financial Officer, are scheduled to present at the H.C. Wainwright 28^th Annual Global Investment Conference, taking place September 14−16, 2026 in New York City.

“The receipt of FDA De Novo Clearance

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

Tue, 01 Sep 2026 08:30:00 -0400

Company to Highlight Growth Strategy and Readiness for 2026 Commercial Launch of FDA-Cleared DeepView® System for Burn Indication

“The receipt of FDA De Novo Clearance

Form 4 Spectral AI, Inc. For: Aug 13 Filed by: DiMaio John Michael

Mon, 17 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260817/26938218.html

Form 4 Spectral AI, Inc. For: Aug 13 Filed by: DiMaio John Michael

Mon, 17 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260817/26938218.html

Form SCHEDULE 13G Spectral AI, Inc. Filed by: LMR Partners LLP

Fri, 14 Aug 2026 09:48:00 -0400

si-local-file:///var/storage/secattach/20260814/26925949.html

Form SCHEDULE 13G Spectral AI, Inc. Filed by: LMR Partners LLP

Fri, 14 Aug 2026 09:48:00 -0400

si-local-file:///var/storage/secattach/20260814/26925949.html

Form 8-K Spectral AI, Inc. For: Aug 11

Wed, 12 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26912630.html

Form 8-K Spectral AI, Inc. For: Aug 11

Wed, 12 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26912630.html

Spectral AI, Inc. (MDAI) Tops Q2 EPS by 2c

Tue, 11 Aug 2026 16:30:08 -0400

Spectral AI, Inc. (NASDAQ: MDAI) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Spectral AI, Inc. (MDAI) click here.

Spectral AI Announces 2026 Second Quarter Financial Results

Tue, 11 Aug 2026 16:05:00 -0400

Company Continues to Advance Towards First Commercial Sales of the DeepView® System for Burn Indication

Strong Cash Position of $14.0 Million at June 30, 2026

DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the second quarter ended June 30, 2026 (“Q2 2026”).

“Spectral AI has entered the second half of 2026 with tremendous momentum and a clear sense of purpose,” said

Spectral AI Announces 2026 Second Quarter Financial Results

Tue, 11 Aug 2026 16:05:00 -0400

Company Continues to Advance Towards First Commercial Sales of the DeepView® System for Burn Indication

Strong Cash Position of $14.0 Million at June 30, 2026

“Spectral AI has entered the second half of 2026 with tremendous momentum and a clear sense of purpose,” said

Form 10-Q Spectral AI, Inc. For: Jun 30

Tue, 11 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260811/26905469.html

Form 10-Q Spectral AI, Inc. For: Jun 30

Tue, 11 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260811/26905469.html

Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call

Wed, 29 Jul 2026 16:15:00 -0400

DALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2026 on Tuesday, August 11, 2026, after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results.

Investors interested in participating in the live call

Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call

Wed, 29 Jul 2026 16:15:00 -0400

Investors interested in participating in the live call

Northland Assumes Spectral AI (MDAI) at Outperform

Mon, 27 Jul 2026 09:28:36 -0400

Northland analyst Luke Horton assumes coverage on Spectral AI (NASDAQ: MDAI) with a Outperform rating and a price target of $4.00.

The analyst comments "We are transferring coverage to Luke Horton from the prior covering analyst and reiterate our views on the company. In May, MDAI achieved its biggest milestone in company history with FDA De Novo clearance for its DeepView System. The focus is now shifting to the commercial rollout of DeepView, and in preparation for this, MDAI appointed the prior CFO to CEO in February, brought in a new CFO in May, and hired a Chief Commercial Officer in

Northland Assumes Spectral AI (MDAI) at Outperform

Mon, 27 Jul 2026 09:28:36 -0400

Northland analyst Luke Horton assumes coverage on Spectral AI (NASDAQ: MDAI) with a Outperform rating and a price target of $4.00.

Northland Assumes Spectral AI (MDAI) at Outperform

Mon, 27 Jul 2026 09:28:36 -0400

Northland analyst Luke Horton assumes coverage on Spectral AI (NASDAQ: MDAI) with a Outperform rating and a price target of $4.00.

Form 8-K Spectral AI, Inc. For: Jul 07

Wed, 08 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260708/26747478.html

Form 8-K Spectral AI, Inc. For: Jul 07

Wed, 08 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260708/26747478.html

Spectral AI names Darcy Bajko as chief commercial officer

Wed, 08 Jul 2026 08:30:09 -0400

Spectral AI, Inc. (Nasdaq: MDAI) announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Bajko will oversee commercial operations for the global launch of the company's DeepView System for burn indication, which received De Novo Classification from the U.S. Food and Drug Administration in May 2026.

Bajko joins Spectral AI from MediView XR, where she spent five years in commercial leadership roles, most recently as Vice President of Commercialization and Customer Success. At MediView XR, she was involved in launching three FDA-cleared augmented reality imaging platforms. Before that, she held commercial roles at Smith+Nephew, Integra LifeSciences,

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

Wed, 08 Jul 2026 08:30:00 -0400

Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education

DALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Ms. Bajko will lead the commercial functions in support of Spectral AI’s global launch of its DeepView^® System for burn indication, which was granted De Novo Classification by the U.S. Food

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

Wed, 08 Jul 2026 08:30:00 -0400

Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education

Form 4 Spectral AI, Inc. For: Jun 24 Filed by: DiMaio John Michael

Mon, 29 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260629/26706293.html

Form 4 Spectral AI, Inc. For: Jun 24 Filed by: DiMaio John Michael

Mon, 29 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260629/26706293.html